The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Antimicrobial peptides in the female reproductive tract: a critical component of the mucosal immune barrier with physiological and clinical implications
Open accessAbstract
BACKGROUND: At the interface of the external environment and the mucosal surface of the female reproductive tract (FRT) lies a first-line defense against pathogen invasion that includes antimicrobial peptides (AMP). Comprised of a unique class of multifunctional, amphipathic molecules, AMP employ a wide range of functions to limit microbial invasion and replication within host cells as well as independently modulate the immune system, dampen inflammation and maintain tissue homeostasis. The role of AMP in barrier defense at the level of the skin and gut has received much attention as of late. Given the far reaching implications for women's health, maternal and fetal morbidity and mortality, and sexually transmissible and polymicrobial diseases, we herein review the distribution and function of key AMP throughout the female reproductive mucosa and assess their role as an essential immunological barrier to microbial invasion throughout the reproductive cycle of a woman's lifetime. METHODS: A comprehensive search in PubMed/Medline was conducted related to AMP general structure, function, signaling, expression, distribution and barrier function of AMP in the FRT, hormone regulation of AMP, the microbiome of the FRT, and AMP in relation to implantation, pregnancy, fertility, pelvic inflammatory disease, complications of pregnancy and assisted reproductive technology. RESULTS: AMP are amphipathic peptides that target microbes for destruction and have been conserved throughout all living organisms. In the FRT, several major classes of AMP are expressed constitutively and others are inducible at the mucosal epithelium and by immune cells. AMP expression is also under the influence of sex hormones, varying throughout the menstrual cycle, and dependent on the vaginal microbiome. AMP can prevent infection with sexually transmissible and opportunistic pathogens of the female reproductive tissues, although emerging understanding of vaginal dysbiosis suggests induction of a unique AMP profile with increased susceptibility to these pathogens. During pregnancy, AMP are key immune effectors of the fetal membranes and placenta and are dysregulated in states of intrauterine infection and other complications of pregnancy. CONCLUSIONS: At the level of the FRT, AMP serve to inhibit infection by sexually and vertically transmissible as well as by opportunistic bacteria, fungi, viruses, and protozoa and must do so throughout the hormone flux of menses and pregnancy. Guarding the exclusive site of reproduction, AMP modulate the vaginal microbiome of the lower FRT to aid in preventing ascending microbes into the upper FRT. Evolving in parallel with, and in response to, pathogenic insults, AMP are relatively immune to the resistance mechanisms employed by rapidly evolving pathogens and play a key role in barrier function and host defense throughout the FRT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Holick, M. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmra070553 · Cited by 13,720
Pattern Recognition Receptors and Inflammation
Takeuchi, O., & Akira, S. (2010) · Cell · doi:10.1016/j.cell.2010.01.022 · Cited by 8,895
Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394 · cited 1×
“These carbohydrate-binding domain aids in pattern recognition of PRR ligands, including LPS and mannan (Janeway and Medzhitov, 2002).”
BackgroundAntimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829
Dominguez-Bello, M. G., Costello, E. K., Contreras, M., Magris, M., Hidalgo, G., Fierer, N., & Knight, R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002601107 · Cited by 4,774
Defensins: antimicrobial peptides of innate immunity
Ganz, T. (2003) · Nature Reviews Immunology · doi:10.1038/nri1180 · Cited by 3,066
Neutrophils and immunity: challenges and opportunities
Nathan, C. (2006) · Nature reviews. Immunology · doi:10.1038/nri1785 · Cited by 2,971 · cited 2×
“HNP1-4 are predominately made by neutrophils and stored in their primary (azurophil) granules along with myeloperoxidase, bacterial/ permeability-increasing (BPI) peptide, and four proteases including protease-3, cathepsin G, elastase and azurocidin (Faurschou and Borregaard, 2003; Nathan, 2006).”
BackgroundIntrauterine infection and preterm delivery
Goldenberg, R. L., Hauth, J. C., & Andrews, W. W. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005183422007 · Cited by 2,548 · cited 7×
“After the amniotic cavity is sealed off, the likelihood of infection is decreased, which suggests that the intrauterine infection is more likely to result from chronic infection and that the timeline for initiation of infection in the uterus occurs before conception and up to mid-pregnancy (Goldenberg et al., 2000).”
BackgroundInfluentialIncidence of early loss of pregnancy
Wilcox, A. J., Weinberg, C. R., O'Connor, J. F., Baird, D. D., Schlatterer, J. P., Canfield, R. E., Armstrong, E. G., & Nisula, B. C. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807283190401 · Cited by 2,354
Endogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis
Ong, P. Y., Ohtake, T., Brandt, C., Strickland, I., Boguniewicz, M., Ganz, T., Gallo, R. L., & Leung, D. Y. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021481 · Cited by 1,960 · cited 2×
“Moreover, LL-37 is induced by, and is synergistic with, a variety of other AMP including HNP1 (Nagaoka et al., 2000), HBD2 (Ong et al., 2002), lactoferrin and lysozyme (Bals et al., 1998).”
BackgroundCrosstalk in NF-κB Signaling Pathways
Oeckinghaus, A., Hayden, M. S., & Ghosh, S. (2011) · Nature Immunology · doi:10.1038/ni.2065 · Cited by 1,942
Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide
Lande, R., Gregorio, J., Facchinetti, V., Chatterjee, B., Wang, Y.-H., Homey, B., Cao, W., Wang, Y.-H., Su, B., Nestle, F. O., et al. (2007) · Nature · doi:10.1038/nature06116 · Cited by 1,910 · cited 8×
“Endometrial HBD1 mRNA and protein expression is maximal during the mid-luteal phase, whereas HBD2, HBD3 and HBD4 peak at different times throughout the menstrual cycle and are not correlated with the implantation window (King et al., 2003b; Das et al., 2007).”
BackgroundInfluentialβ-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6
Yang, D., Chertov, O., Bykovskaia, S. N., Chen, Q., Buffo, M. J., Shogan, J., Anderson, M., Schröder, J. M., Wang, J. M., Howard, O. M. Z., et al. (1999) · Science · doi:10.1126/science.286.5439.525 · Cited by 1,809 · cited 4×
“…et al., 2010), macrophages (Garcia et al., 2001), monocyte-derived DC (Presicce et al., 2009), mast cells (Niyonsaba et al., 2002a) and neutrophils (Yang et al., 1999; Niyonsaba et al., 2004). b-Defensins also induce maturation of monocyte-derived DC with increased expression of co-stimulatory…”
BackgroundInfluentialAssociation between Bacterial Vaginosis and Preterm Delivery of a Low-Birth-Weight Infant
Hillier, S. L., Nugent, R. P., Eschenbach, D. A., Krohn, M. A., Gibbs, R. S., Martin, D. H., Cotch, M. F., Edelman, R., Pastorek, J. G., Rao, A. V., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512283332604 · Cited by 1,492
Neutrophil granules and secretory vesicles in inflammation
Faurschou, M., & Borregaard, N. (2003) · Microbes and Infection · doi:10.1016/j.micinf.2003.09.008 · Cited by 1,162 · cited 9×
“Azurophil granules have limited participation in degranulation, thus defensins stored in these granules are primarily intended for engulfed pathogens within the phagolysosome (Faurschou and Borregaard, 2003; Nathan, 2006).”
BackgroundInfluentialA component of innate immunity prevents bacterial biofilm development
Singh, P. K., Parsek, M. R., Greenberg, E. P., & Welsh, M. J. (2002) · Nature · doi:10.1038/417552a · Cited by 1,026 · cited 2×
“Additional antimicrobial mechanisms exhibited by lactoferrin include, proteolytic degradation of virulence mechanisms from Type III secretion systems (Ochoa and Clearly, 2004), direct inhibition of host invasion (de Araujo and Giugliano, 2001), inhibition of biofilm formation (Singh et al., 2002), promotion of apoptos…”
BackgroundRomero, R., Hassan, S. S., Gajer, P., Tarca, A. L., Fadrosh, D. W., Nikita, L., Galuppi, M., Lamont, R. F., Chaemsaithong, P., Miranda, J., et al. (2014) · Microbiome · doi:10.1186/2049-2618-2-4 · Cited by 852
Koumans, E. H., Sternberg, M., Bruce, C., McQuillan, G., Kendrick, J., Sutton, M., & Markowitz, L. E. (2007) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318074e565 · Cited by 761 · cited 1×
“Clinically, this is known as bacterial vaginosis (BV) and is the most common vaginal disorder among women of reproductive age (Koumans et al., 2007).”
BackgroundAgerberth, B., Charo, J., Werr, J., Olsson, B., Idali, F., Lindbom, L., Kiessling, R., Jörnvall, H., Wigzell, H., & Gudmundsson, G. H. (2000) · Blood · doi:10.1182/blood.v96.9.3086 · Cited by 758
Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection
Gläser, R., Harder, J., Lange, H., Bartels, J., Christophers, E., & Schröder, J.-M. (2005) · Nature Immunology · doi:10.1038/ni1142 · Cited by 651 · cited 2×
“Psoriasin expression is also inducible by exposure of keratinocytes to supernatants of E. coli or the microbial product flagellin (Glaser et al., 2005; Abtin et al., 2008).”
BackgroundSurfactant proteins SP-A and SP-D: structure, function and receptors
Kishore, U., Greenhough, T. J., Waters, P., Shrive, A. K., Ghai, R., Kamran, M. F., Bernal, A. L., Reid, K. B. M., Madan, T., & Chakraborty, T. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2005.08.004 · Cited by 523
Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study
Pütsep, K., Carlsson, G., Boman, H. G., & Andersson, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11201-3 · Cited by 499 · cited 1×
“AMP are vital to human health, as exemplified by patients with morbus Kostmann (severe congenital neutropenia) where key AMP are absent, resulting in severe periodontal disease (Putsep et al., 2002).”
BackgroundCompartmentalized and systemic control of tissue immunity by commensals
Belkaid, Y., & Naik, S. (2013) · Nature Immunology · doi:10.1038/ni.2604 · Cited by 382 · cited 1×
“How the FRT microbiome interfaces with the human barrier defense system (epithelial and immune) and vice versa is only beginning to be understood (Belkaid and Naik, 2013).”
BackgroundDistinct Effects of Surfactant Protein A or D Deficiency During Bacterial Infection on the Lung
LeVine, A. M., Whitsett, J. A., Gwozdz, J. A., Richardson, T. R., Fisher, J. H., Burhans, M. S., & Korfhagen, T. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.7.3934 · Cited by 352 · cited 1×
“Both can inactivate virus and aid in phagocytosis of microbes through opsonization and phagocytic functions including simulation of oxidative burst and production of proinflammatory cytokines from these cells (Benne et al., 1995; LeVine et al., 2000) as depicted in Fig.”
BackgroundInfluence of bacterial vaginosis on conception and miscarriage in the first trimester: cohort study
Ralph, S. G., Rutherford, A. J., & Wilson, J. D. (1999) · BMJ · doi:10.1136/bmj.319.7204.220 · Cited by 290
Nagaoka, I., Hirota, S., Niyonsaba, F., Hirata, M., Adachi, Y., Tamura, H., & Heumann, D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.6.3329 · Cited by 258 · cited 2×
“These functions include neutralization of lipopolysaccharide (LPS) (Larrick et al., 1995; Nagaoka et al., 2001), modulation of cytokine release (Davidson et al.”
BackgroundBellamy, W., Wakabayashi, H., Takase, M., Kawase, K., Shimamura, S., & Tomita, M. (1993) · Medical Microbiology and Immunology · doi:10.1007/bf00189377 · Cited by 219
Cited by
Perez-Muñoz, M. E., Arrieta, M.-C., Ramer-Tait, A. E., & Walter, J. (2017) · Microbiome · doi:10.1186/s40168-017-0268-4 · Cited by 1,096
The vaginal microbiota, host defence and reproductive physiology
Smith, S. B., & Ravel, J. (2017) · The Journal of Physiology · doi:10.1113/jp271694 · Cited by 441
Elovitz, M. A., Gajer, P., Riis, V., Brown, A. G., Humphrys, M. S., Holm, J. B., & Ravel, J. (2019) · Nature Communications · doi:10.1038/s41467-019-09285-9 · Cited by 370
Menopause and the vaginal microbiome
Muhleisen, A. L., & Herbst-Kralovetz, M. M. (2016) · Maturitas · doi:10.1016/j.maturitas.2016.05.015 · Cited by 328
Self-citationDoes the vaginal microbiota play a role in the development of cervical cancer?
Kyrgiou, M., Mitra, A., & Moscicki, A.-B. (2017) · Translational Research · doi:10.1016/j.trsl.2016.07.004 · Cited by 282
Metadata
- Authors
- Yarbrough, V. L., Winkle, S., & Herbst-Kralovetz, M. M.
- Venue
- Human Reproduction Update
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-12-29
- Volume
- 21
- Issue
- 3
- Pages
- 353-377
- ISSN
- 1355-4786 (ISSN-L)
- 1460-2369
- OpenAlex
- W2149077143
- Cited by
- 209
- References
- 27
- FWCI
- 7.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.